Neural regeneration ability of Polypyrrole-Collagen-Quercetin composite in the spinal cord injury.
Antioxidant
Collagen
Electrical conductivity
Quercetin
Spinal cord regeneration
Journal
Regenerative therapy
ISSN: 2352-3204
Titre abrégé: Regen Ther
Pays: Netherlands
ID NLM: 101709085
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
14
03
2023
revised:
22
05
2023
accepted:
28
05
2023
medline:
19
6
2023
pubmed:
19
6
2023
entrez:
19
6
2023
Statut:
epublish
Résumé
Spinal cord injury (SCI) is a major clinical problem in young patients. The major hurdle in SCI regeneration is the replacement of lost nerve communication signals due to injury. Here we have prepared a biocompatible electrical conductive composite such as Collagen-Polypyrrole combined with Quercetin (Col-PPy-Qur) composite. The prepared composites are characterized for their chemical functionality and morphology by the FTIR and SEM & TEM analysis, respectively. The Col-PPy-Qur composite observed electrical conductivity at 0.0653 s/cm due to the conductive Polypyrrole polymer present in the composite. The Col-PPy-Qur composite exhibits a mechanical strength of 0.1281 mPa, similar to the native human spinal cord's mechanical strength. In order to explore the regeneration potential, the viability of the composite has been tested with human astrocyte cells (HACs). The Tuj1 and GFAF marker expression was quantized by RT-PCR analysis. Increased Tuj1 and decreased GFAF expression by the Col-PPy-Qur composite indicated the potential differentiation ability of the HACs into neuron cells. The results indicated that the Col-PPy-Qur composite could have good regeneration and differentiation ability, better biocompatibility, and suitable mechanical and conductivity properties. It can act as an excellent strategy for spinal cord regeneration in the nearer future.
Identifiants
pubmed: 37334243
doi: 10.1016/j.reth.2023.05.010
pii: S2352-3204(23)00048-2
pmc: PMC10275702
doi:
Types de publication
Journal Article
Langues
eng
Pagination
85-93Informations de copyright
© 2023 The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
J Neurochem. 2005 May;93(4):943-52
pubmed: 15857397
Soft Matter. 2018 Jan 24;14(4):574-580
pubmed: 29334392
CNS Neurosci Ther. 2019 Sep;25(9):951-964
pubmed: 31486601
Int J Pharm. 2001 Jun 19;221(1-2):1-22
pubmed: 11397563
Stem Cells Int. 2020 Nov 05;2020:2853650
pubmed: 33204276
Acta Biomater. 2022 Feb;139:43-64
pubmed: 33326879
Rev Neurosci. 2017 Jan 1;28(1):87-101
pubmed: 28045676
Nat Nanotechnol. 2018 Aug;13(8):755-764
pubmed: 29892019
EJNMMI Res. 2016 Dec;6(1):38
pubmed: 27115744
Org Process Res Dev. 2020 Jan 17;24(1):25-31
pubmed: 34092997
PLoS One. 2013 May 29;8(5):e65438
pubmed: 23734254
ACS Appl Mater Interfaces. 2021 Oct 26;:
pubmed: 34699166
Neural Regen Res. 2021 Sep;16(9):1829-1835
pubmed: 33510090
Int J Biol Macromol. 2021 Jan 15;167:434-445
pubmed: 33278434
Sci Technol Adv Mater. 2015 May 5;16(3):035001
pubmed: 27877802
Int J Med Sci. 2018 Jan 1;15(1):36-45
pubmed: 29333086
Biomed Res Int. 2022 Apr 26;2022:8962149
pubmed: 35528172
Biophys J. 2012 Feb 8;102(3):452-60
pubmed: 22325267
J Food Sci. 2019 Oct;84(10):2883-2897
pubmed: 31553062
Curr Drug Discov Technol. 2012 Mar;9(1):17-24
pubmed: 21644920
J Cell Biochem. 2018 Feb;119(2):2298-2306
pubmed: 28865131
Biopolymers. 2008 May;89(5):338-44
pubmed: 17941007
Regen Biomater. 2021 Aug 12;8(6):rbab047
pubmed: 34513004
Front Neurol. 2022 May 20;13:905640
pubmed: 35669881
Int J Mol Sci. 2020 Oct 13;21(20):
pubmed: 33066029
Glia. 2003 Jul;43(1):87-90
pubmed: 12761871
ACS Nano. 2018 Nov 27;12(11):10957-10967
pubmed: 30285411
RSC Adv. 2018 Jul 23;8(46):26218-26229
pubmed: 35541968
Neural Regen Res. 2021 Nov;16(11):2284-2292
pubmed: 33818514
J Neurotrauma. 2003 Jun;20(6):583-91
pubmed: 12906742
Biophys Chem. 2004 Dec 20;112(2-3):267-76
pubmed: 15572258
Biomed Pharmacother. 2019 Feb;110:906-917
pubmed: 30572195
Front Neurol. 2019 Mar 22;10:282
pubmed: 30967837
Neural Regen Res. 2019 Aug;14(8):1352-1363
pubmed: 30964053
Adv Healthc Mater. 2021 Apr;10(8):e2001896
pubmed: 33522126